↑ View All References

Antibiotic Resistance and the Staphylococci, 2nd Edition References

Boucher, H., Wilcox, M., Talbot, G., Puttagunta, S., Das, A., & Dunne, M. (2014). Once-weekly dalbavancin versus daily conventional therapy for skin infection. New England Journal of Medicine, 370, 2169-2179.

Bukharie, H. A. (2010). A review of community-acquired methicillin-resistant Staphylococcus aureus for primary care physicians. Journal of Family and Community Medicine, 17(3), 117-120.

Depardieu, F., Podglajen, I., Leclercq, R., Collatz, E., & Courvalin, P. (2007). Modes and modulations of antibiotic resistance gene expression. Clinical Microbiology Reviews, 20(1), 79-114.

Djurkovic, Loeffler, & Fischetti. (2005). Synergistic killing of Streptococcus pneumoniae with the bacteriophage lytic enzyme Cpl-1 and penicillin or gentamicin depends on the level of penicillin resistance. Antimicrobial Agents and Chemotherapy, 49(3), 1225-1228.

Evans, R. (2008). The silent epidemic: CA-MRSA and HA-MRSA. Rosemont, IL: American Academy of Orthopaedic Surgeons.

Fischer, K. (2014). FDA approves new drug for MRSA infections, but bacterial threats remain. Retrieved from http://www.healthline.com/ health-news/new-mrsa-drug-approved-081214

Fletcher, J. T., Finlay, J. A., Callow, M. E., Callow, J. A., & Ghadiri, M. R. (2007). A combinatorial approach to the discovery of biocidal six-residue cyclic D,L-alphapeptides against the bacteria methicillinresistant Staphylococcus aureus (MRSA) and E. coli and the biofouling algae Ulva linza and Navicula perminuta. Chemistry, 13(14), 4008- 4013.

Hancock, R. (2005). Mechanisms of action of newer antibiotics for gram-positive pathogens. The Lancet Infectious Diseases, 5(4), 209-218.

Huang, S., Yokoe, D., Hinrichsen, V., Spurchise, L., Datta, R., Miroshnik, I., & Platt, R. (2006). Impact of routine intensive care unit surveillance cultures and resultant barrier precautions on hospital-wide methicillinresistant Staphylococcus aureus bacteremia. Clinical Infectious Diseases, 43(8), 971-978.

Jian, H., Xiao, X., Yuan, T., Long, P., Long, Z., & Hong, S. (2013). Reduced vancomycin susceptibility found in methicillin-resistant and methicillin-sensitive Staphylococcus aureus clinical isolates in northeast China. PLOS ONE. Retrieved from http://journals. plos.org/plosone/article?id=10.1371/journal. pone.0073300

John, J. F., Jr., Davidson, R. J., & Low, D. E. (2010). Staphylococcus epidermidis and other coagulase-negative staphylococci. Antimicrobe: Infectious Disease and Antimicrobial Agents. Retrieved from http:// www.antimicrobe.org/new/b234.asp

Lebeaux, D., Ghigo, J., & Beloin, C. (2014). Biofilm-related infections: Bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics. Microbiology and Molecular Biology Reviews, 78(3), 510-543.

Lockhart, P. B., Brennan, M. T., Fox, P. C., Norton, H. J., Jernigan, D. B., Strausbaugh, L. J., & Infectious Diseases Society of America Emerging Infections Network. (2002). Decision-making on the use of antimicrobial prophylaxis for dental procedures: A survey of infectious disease consultants and review. Clinical Infectious Diseases, 34(12), 1621-1626.

Marcinkiewics, J., Strus, M., & Pasich, E. (2011). Antibiotic resistance: A “dark side” of biofilm-associated chronic infections. Polskie Archiwum Medycyny Wewnętrznej, 123(6), 309-313.

McNamee, D. (2014). A single shot of antibiotic could be new MRSA treatment. Retrieved from http://www.medicalnews today.com/articles/277796.php

Musafer, H., Kuchma, S., Naimie, A., Schwartzman, J., Fahad, A., Harith, J., & O’Toole, G. (2013). Investigating the link between imipenem resistance and biofilm formation by Pseudomonas aeruginosa. Microbial Ecology, 68(1), 111-120. doi:10.1007/s00248-013-0361-6

Ng, S., Lim, C., Tan, C., Haron, H., Ahmad, N., & Murugaiyah, V. (2011). Emergence of vancomycin-resistant Staphylococcus aureus (VRSA). Retrieved from https://www.web medcentral.com/article_view/2787

Oglesby-Sherrouse, A., Djapgne, L., Nguyen, A., Vasil, A., & Vasil, M. (2014). The complex interplay of iron, biofilm formation, and mucoidy affecting antimicrobial resistance of Pseudomonas aeruginosa. Pathogens and Disease, 70(3), 307-320. doi:10.1111/2049-632X.12132

Vandecandelaere, I., Matthijs, N., van Nieuwerburgh, F., Deforce, D., Vosters, P., de Bus, L., … Coenye, T. (2012). Assessment of microbial diversity in biofilms recovered from endotracheal tubes using culture dependent and independent approaches. PLOS ONE, 7(6). doi:10.1371/journal.pone. 0038401

Walker, T. (2014). FDA approves a new antibiotic to treat MRSA. Retrieved from http:// formularyjournal.modernmedicine.com/ formulary-journal/content/tags/absssi/fdaapproves- new-antibiotic-treat-mrsa?page=full

Wertheim, H., Melles, D. C., Vos, M. C., van Leeuwen, W., van Belkum, A., Verbrugh, H. A., & Nouwen, J. L. (2005). The role of nasal carriage in Staphylococcus aureus infections. The Lancet Infectious Diseases, 5(12), 751-762.